Here, we decipher the cis-regulatory logic of ERα-mediated transcriptional response to estrogen in breast cancer cells, through an integrative approach that leverages the power of multi-omics data, and benefits from combining sequence analysis and mechanistically grounded biophysical models. The gene discussed is ESR1; the disease is breast carcinoma.